Clinical trial
Pharmacokinetic Evaluations of Ixekizumab Following Subcutaneous Administration Using Prefilled Syringe or Auto-Injector in Patients With Moderate-to-Severe Plaque Psoriasis
The purpose of this study is to evaluate the serum concentration of ixekizumab after administration using either prefilled syringe or auto-injector in participants with moderate to severe plaque psoriasis. Treatment period is followed by 40 weeks optional safety extension.
| Category | Value |
|---|---|
| Date last updated at source | 2016-09-13 |
| Study type(s) | Interventional |
| Expected enrolment | 204 |
| Study start date | 2013-03-13 |
| Estimated primary completion date | 2015-05-01 |